| dbo:abstract
|
- Arachidonyl trifluoromethyl ketone (ATK) is an analog of arachidonic acid. that inhibits some isoforms of the enzyme phospholipase A2. Specifically it inhibits the 85 kDa cystolic PLA2 (cPLA2). It has been studied as a neuroprotective agent after spinal cord injury, and in animal models of multiple sclerosis. (en)
|
| dbo:iupacName
|
- (6Z,9Z,12Z,15Z)-1,1,1-Trifluorohenicosa-6,9,12,15-teraen-2-one (en)
|
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 3505 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:imagefile
|
- Arachidonyl trifluoromethyl ketone.svg (en)
|
| dbp:imagesize
| |
| dbp:pin
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Arachidonyl trifluoromethyl ketone (ATK) is an analog of arachidonic acid. that inhibits some isoforms of the enzyme phospholipase A2. Specifically it inhibits the 85 kDa cystolic PLA2 (cPLA2). It has been studied as a neuroprotective agent after spinal cord injury, and in animal models of multiple sclerosis. (en)
|
| rdfs:label
|
- Arachidonyl trifluoromethyl ketone (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
